Mycobacterium tuberculosis susceptibility in Saudi Arabia

Saudi Medical Journal

Volumn 23, Issue 10, 2002, Pages 1227-1231

  Alrajhi, Abdulrahman ^a   Al Barrak, Ali M ^b  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; DRUG SENSITIVITY; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PUBLICATION; SAUDI ARABIA;

DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SAUDI ARABIA;

EID: 0036816633     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
2. Raviglione MC, Dye C, Schmidt S, Kochi A. Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project. Lancet 1997; 350: 624-629.
3. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545.
4. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65-68.
5. World Health Organization (WHO). Anti-tuberculosis Drug Resistance in the World. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1994-1997. Geneva; 1997. p. 51.
6. Schwoebel V, Lambregts-van Weezenbeek CS, Moro ML, Drobniewski F, Hoffner SE, Raviglione MC et al. Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J 2000; 16: 364-371.
7. Schiott CR, Engbaek HC, Vergmann B, Al Motez M, Kassim I. Incidence of drug resistance amongst isolates of Mycobacterium tuberculosis recovered in the Gizan area, Saudi Arabia. Saudi Med J 1985; 6: 375-378.
8. Al-Orainey IO. Resistance to standard antituberculous drugs in Saudi Arabia, Saudi Med J 1986; 7: 363-368.
9. Al-Orainey IO, Saeed ES, El-Kassimi FA, Al-Shareef N. Resistance to antituberculosis drugs in Riyadh, Saudi Arabia. Tubercle 1989; 70: 207-210.
10. Zaman R. Tuberculosis in Saudi Arabia: initial and secondary drug resistance among indigenous and non-indigenous populations. Tubercle 1991; 72: 51-55.
11. Jarallah JS, Elias AK, Al Hajjaj MS, Bukhari MS, Al Shareef AH, Al-Shammari SA. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tuber Lung Dis 1992; 73: 113-115.
12. Chowdhury MNH, Kambal AM. Mycobacterial resistance in a general hospital in Riyadh Saudi Arabia. Medical Science Research 1992; 20: 21-22.
13. Ellis ME, Al-Hajjar S, Bokhari H, Qadri SM. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia. Scand J Infect Dis 1996; 28: 591-595.
14. Kinsara AJ. Review of non-tuberculous mycobacteria. King Khalid National Guard Hospital, Jeddah. Saudi Med J 1998; 19: 212-214.
15. Al-Jama AA, Borgio FG, Al-Qatari KM. Patterns of resistance to antituberculous drugs in Eastern Province, Saudi Arabia. Saudi Med J 1999; 20: 927-930.
16. Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Int J Antimicrob Agents 2001; 17: 415-418.
17. Al-Rubaish AM, Madania AA, Al-Muhanna FA. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Saudi Med. 1 2001; 22: 776-779.
18. Alrajhi AA, Abdulwahab S, Almodovar E, Al-Abdely HM. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J 2002; 23: 305-310.
19. Ioannidis JP, Lau J. State of the evidence: Current status and prospects of meta-analysis in infectious diseases. Clin Infect Dis 1999; 29: 1178-1185.
20. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 1997; 24: S121 -S130.
21. Araj GF, Itani LY, Kanj NA, Jamaleddine GW. Comparative study of antituberculous drug resistance among Mycobacterium tuberculosis isolates recovered at the American University of Beirut Medical Center: 1996-1998 vs 1994-1995. Lebanese Medical Journal 2000; 48: 18-22.
22. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-1303.
23. Remis RS, Jamieson F, Chedore P, Haddad A, Vernich L. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998. Clin Infect Dis 2000; 31: 427-432.